Back to Agenda
Russia and the Eurasian Union – Regulatory Challenges and Opportunities
Session Chair(s)
Susanne Ausborn, PHD
Global Head International Regulatory Policy, Roche, Switzerland
The regulatory landscape in Russia and the “single market” of the Eurasian Union are rapidly evolving. Experts will share their perspectives on recent developments in the region and discuss the challenges we are facing with sometime very unique regulatory requirements. Examples for constructive dialogue between industry and regulators will be shared which is critical to bring and safe and efficacious drugs of high quality as fast as possible to the patients and maintain them on the market.
Speaker(s)
Dmitriy Rozdestvensky, MD, PHD
Head, Division for Coordination of Common Market for Drugs and Medical Devices F, Eurasian Economic Commission, Russian Federation
Regulatory Harmonisation within the Eurasian Union – Where Do We Stand?
Sergey Glagolev
Deputy Chief, Division for State Control of Medical Products, Federal Service for Supervision in Health Care (Rosdravnadzor), Russian Federation
Regulatory Harmonisation within the Eurasian Union – Where Do We Stand?
Elena Popova, DrMed
Senior Director Regulatory Affairs & Healthcare Policy, Association of International Pharmaceutical Manufacturers (AIPM), Russian Federation
Establishing EEU Guidance - Driving Towards Regulatory Convergence - Industry Perspective
Andrey Bulimov
Head of International Regulatory Affairs, Ironwood Pharmaceuticals, Switzerland
Recent Developments and Challenges in Russia - Industry Perspective
Have an account?